크라이오셀 인터내셔널 (CCEL) 주가

크라이오셀 인터내셔널(CCEL)는 NYSE MKT에 상장된 Healthcare · Medical Care Facilities 기업입니다. 현재가 $3.96 (+1.67%), 시가총액 $0.03B, 52주 범위 $2.89 ~ $5.48.

Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to

핵심 지표

• 현재가: $3.96 (+1.67%)
• 시가총액: $0.03B
• 52주 최저~최고: $2.89 ~ $5.48
• 섹터: Healthcare
• 산업: Medical Care Facilities
• 거래소: NYSE MKT

크라이오셀 인터내셔널의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.

크라이오셀 인터내셔널 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 9.72
• 순이익률: -0.09%
• 영업이익률: 0.10%
• 배당수익률: 0.04%

자주 묻는 질문